| 1 |
Tobacco smoking and its drug interactions with comedications involving CYP and UGT enzymes and nicotine 
Naina Mohamed Pakkir Maideen
World J Pharmacol
8(2):14-25.
Published online Jan 30, 2019.
doi: 10.5497/wjp.v8.i2.14
|
| 2 |
Ocular drug delivery systems: An overview
Ashaben Patel, Kishore Cholkar, Vibhuti Agrahari, Ashim K Mitra
World J Pharmacol
2(2):47-64.
Published online Jun 9, 2013.
doi: 10.5497/wjp.v2.i2.47
|
| 3 |
Dried-leaf Artemisia annua: A practical malaria therapeutic for developing countries?
Patrick Ogwang Engeu, Pierre Lutgen, Ahmed Hassanali, Melissa Towler, Pamela J Weathers
World J Pharmacol
3(4):39-55.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.39
|
| 4 |
Role of mitogen- and stress-activated kinases in inflammatory arthritis
Weili Hui, Sylvain G Bourgoin
World J Pharmacol
4(4):265-273.
Published online Dec 9, 2015.
doi: 10.5497/wjp.v4.i4.265
|
| 5 |
Updates on therapies for chronic prostatitis/chronic pelvic pain syndrome
Asfandyar Khan, Adam B Murphy
World J Pharmacol
4(1):1-16.
Published online Mar 9, 2015.
doi: 10.5497/wjp.v4.i1.1
|
| 6 |
Therapeutic targets and delivery challenges for Alzheimer’s disease
Preshita Desai, Harshad Shete, Rahul Adnaik, John Disouza, Vandana Patravale
World J Pharmacol
4(3):236-264.
Published online Sep 9, 2015.
doi: 10.5497/wjp.v4.i3.236
|
| 7 |
Drug delivery in ocular diseases: Barriers and strategies
Ashim K Mitra, Deep Kwatra
World J Pharmacol
2(4):78-83.
Published online Dec 9, 2013.
doi: 10.5497/wjp.v2.i4.78
|
| 8 |
Controversial usages of kratom ( Mitragyna speciosa): For good or for evil
Murtadha Basheer, Rana Khudhair Jasim, Gam Lay Harn
World J Pharmacol
11(3):16-26.
Published online Nov 28, 2022.
doi: 10.5497/wjp.v11.i3.16
|
| 9 |
Novel strategies for the treatment of diabetic macular edema
Hoang M Trinh, Mary Joseph, Kishore Cholkar, Dhananjay Pal, Ashim K Mitra
World J Pharmacol
5(1):1-14.
Published online Mar 9, 2016.
doi: 10.5497/wjp.v5.i1.1
|
| 10 |
Appropriate prescribing in the elderly: Current perspectives
Amanda Hanora Lavan, John O’Grady, Paul Francis Gallagher
World J Pharmacol
4(2):193-209.
Published online Jun 9, 2015.
doi: 10.5497/wjp.v4.i2.193
|
| 11 |
Non-selective beta-blockers in cirrhosis: Current concepts and controversies
Neil Rajoriya, Dhiraj Tripathi
World J Pharmacol
5(1):15-31.
Published online Mar 9, 2016.
doi: 10.5497/wjp.v5.i1.15
|
| 12 |
How and why chemicals from tobacco smoke can induce a rise in blood pressure
World J Pharmacol
1(1):10-20.
Published online Feb 9, 2012.
doi: 10.5497/wjp.v1.i1.10
|
| 13 |
Tenofovir induced severe thrombocytopenia
Mayank Jain, Joy Vargese, Jayanthi Venkatatraman
World J Pharmacology
6(2):11-13.
Published online Jun 9, 2017.
doi: 10.5497/wjp.v6.i2.11
|
| 14 |
Adalimumab and pharmacokinetics: Impact on the clinical prescription for inflammatory bowel disease
Anne-Laure Pelletier, Pascale Nicaise-Roland
World J Pharmacol
5(1):44-50.
Published online Mar 9, 2016.
doi: 10.5497/wjp.v5.i1.44
|
| 15 |
Emerging pharmacological strategies for the treatment of fibromyalgia
World J Pharmacology
6(1):1-10.
Published online Mar 9, 2017.
doi: 10.5497/wjp.v6.i1.1
|
| 16 |
Pharmacology and clinical applications of flupirtine: Current and future options
World J Pharmacology
8(1):1-13.
Published online Jan 15, 2019.
doi: 10.5497/wjp.v8.i1.1
|
| 17 |
Kv7 channels a potential therapeutic target in fibromyalgia: A hypothesis
World J Pharmacology
7(1):1-9.
Published online Oct 22, 2018.
doi: 10.5497/wjp.v7.i1.1
|
| 18 |
Chemoprevention of gastrointestinal cancers by natural honey
World J Pharmacol
4(1):160-167.
Published online Mar 9, 2015.
doi: 10.5497/wjp.v4.i1.160
|
| 19 |
Bacterial biofilms in human gastrointestinal tract: An intricate balance between health and inflammatory bowel diseases
Sunil Kumar, Ankita Srivastava, Niharika Chandra
World J Pharmacol
8(3):26-40.
Published online Aug 28, 2019.
doi: 10.5497/wjp.v8.i3.26
|
| 20 |
Phosphoprotein phosphatase 1-interacting proteins as therapeutic targets in prostate cancer
Juliana Felgueiras, Margarida Fardilha
World J Pharmacol
3(4):120-139.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.120
|
| 21 |
Drug-transporter interaction testing in drug discovery and development
World J Pharmacol
2(1):35-46.
Published online Mar 9, 2013.
doi: 10.5497/wjp.v2.i1.35
|
| 22 |
Innovate combination of sevoflurane dilution in dimethyl sulfoxide: A stability study by gas chromatography and nuclear magnetic resonance
F Dámaso Fernández-Ginés, Sergio García-Muñoz, Héctor Mateo-Carrasco, Miguel Ángel Rincón-Cervera, Manuel Cortiñas-Sáenz, José Antonio Morales-Molina, Carmen Fernández-Sánchez, Juan Miguel Expósito-López, Ignacio Rodríguez-García
World J Pharmacology
5(3):59-67.
Published online Sep 9, 2016.
doi: 10.5497/wjp.v5.i3.59
|
| 23 |
Targeted approaches for HER2 breast cancer therapy: News from nanomedicine?
Serena Mazzucchelli, Marta Truffi, Luisa Fiandra, Luca Sorrentino, Fabio Corsi
World J Pharmacol
3(4):72-85.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.72
|
| 24 |
Carbapenemases: A worldwide threat to antimicrobial therapy
José Miguel Sahuquillo-Arce, Alicia Hernández-Cabezas, Fernanda Yarad-Auad, Elisa Ibáñez-Martínez, Patricia Falomir-Salcedo, Alba Ruiz-Gaitán
World J Pharmacol
4(1):75-95.
Published online Mar 9, 2015.
doi: 10.5497/wjp.v4.i1.75
|
| 25 |
Allosteric modulation of cholinergic system: Potential approach to treating cognitive deficits of schizophrenia
Shaun Hopper, Madhara Udawela, Elizabeth Scarr, Brian Dean
World J Pharmacol
5(1):32-43.
Published online Mar 9, 2016.
doi: 10.5497/wjp.v5.i1.32
|
| 26 |
Pharmacophore approaches in protein kinase inhibitors design
Sergiy A Starosyla, Galyna P Volynets, Volodymyr G Bdzhola, Andriy G Golub, Sergiy M Yarmoluk
World J Pharmacol
3(4):162-173.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.162
|
| 27 |
Asthma in pregnancy
Hayley K Blackburn, Douglas R Allington, Kendra A Procacci, Michael P Rivey
World J Pharmacol
3(4):56-71.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.56
|
| 28 |
Role of opioid receptor heterodimerization in pain modulation and tolerance development
Annu Mudgal, Santosh Pasha
World J Pharmacol
4(1):144-159.
Published online Mar 9, 2015.
doi: 10.5497/wjp.v4.i1.144
|
| 29 |
Drug therapy for Parkinson’s disease: An update
World J Pharmacol
4(1):117-143.
Published online Mar 9, 2015.
doi: 10.5497/wjp.v4.i1.117
|
| 30 |
Association of serum bilirubin and non-alcoholic fatty liver disease: A feasible therapeutic avenue?
Mohamed S Anwar, John F Dillon, Michael H Miller
World J Pharmacol
3(4):209-216.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.209
|
| 31 |
Hepatocellular carcinoma and multidrug resistance: Past, present and new challenges for therapy improvement
María L Cuestas, José R Oubiña, Verónica L Mathet
World J Pharmacol
4(1):96-116.
Published online Mar 9, 2015.
doi: 10.5497/wjp.v4.i1.96
|
| 32 |
Pharmacokinetics/Pharmacodynamics study of Fixtral SB as compared to supra bioavailable itraconazole and conventional itraconazole
Syed Mujtaba Hussain Naqvi, Monil Yogesh Neena Gala, Snehal Muchhala, Anand Arumugam, Dhananjay Panigrahi, Dipak Patil, Rahul Rathod, Amey Mane
World J Pharmacol
12(1):1-11.
Published online Feb 17, 2023.
doi: 10.5497/wjp.v12.i1.1
|
| 33 |
Long-term potentiation in autonomic ganglia: Potential role in cardiovascular disorders
World J Pharmacol
5(2):51-58.
Published online Jun 9, 2016.
doi: 10.5497/wjp.v5.i2.51
|
| 34 |
Overview on metabolomics in traditional Chinese medicine
Shi Qiu, Ai-Hua Zhang, Hui Sun, Guang-Li Yan, Xi-Jun Wang
World J Pharmacol
3(3):33-38.
Published online Sep 9, 2014.
doi: 10.5497/wjp.v3.i3.33
|
| 35 |
Implantable (Bio)sensors as new tools for wireless monitoring of brain neurochemistry in real time
Donatella Farina, Maria D Alvau, Giulia Puggioni, Giammario Calia, Gianfranco Bazzu, Rossana Migheli, Ottavio Sechi, Gaia Rocchitta, Maria S Desole, Pier Andrea Serra
World J Pharmacol
3(1):1-17.
Published online Mar 9, 2014.
doi: 10.5497/wjp.v3.i1.1
|
| 36 |
Pharmacological management of neuropathic pain in patients with vestibular schwannomas: Experience of the Atlantic Lateral Skull Base Clinic
Andrea LO Hebb, Jana Sawynok, Manohar Bance, Simon Walling, Ken Chisholm, David P Morris
World J Pharmacol
3(2):24-32.
Published online Jun 9, 2014.
doi: 10.5497/wjp.v3.i2.24
|
| 37 |
Use of eltrombopag in thrombocytopenia of liver disease
World J Pharmacol
3(4):186-192.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.186
|
| 38 |
Potential ability of xanthophylls to prevent obesity-associated cancer
Masaru Terasaki, Michihiro Mutoh, Gen Fujii, Mami Takahashi, Rikako Ishigamori, Sonoko Masuda
World J Pharmacol
3(4):140-152.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.140
|
| 39 |
Antimicrobial resistance in clinically important biofilms
Fatemeh Rafii, Mark E Hart
World J Pharmacol
4(1):31-46.
Published online Mar 9, 2015.
doi: 10.5497/wjp.v4.i1.31
|
| 40 |
Progress in pancreatic cancer therapeutics: The potential to exploit molecular targets
Kiruthikah Thillai, Debashis Sarker, Paul Ross
World J Pharmacol
4(2):180-192.
Published online Jun 9, 2015.
doi: 10.5497/wjp.v4.i2.180
|
| 41 |
Recurrent ciprofloxacin induced hypoglycemia in a non-diabetic patient: A case report
Shereen A Dasuqi, Linah M Alshaer, Rasha A Omran, Mohammed A Hamad
World J Pharmacol
12(2):12-17.
Published online Mar 22, 2023.
doi: 10.5497/wjp.v12.i2.12
|
| 42 |
Antibiotic residues in milk and milk products: A momentous challenge for the pharmaceutical industry and medicine
Rima Omairi, Maha Krayem, Sanaa Khaled, Mohamed Salla, Sami El Khatib
World J Pharmacol
11(4):48-55.
Published online Dec 27, 2022.
doi: 10.5497/wjp.v11.i4.48
|
| 43 |
Telomerase activity: An attractive target for cancer therapeutics
Lucia Picariello, Cecilia Grappone, Simone Polvani, Andrea Galli
World J Pharmacol
3(4):86-96.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.86
|
| 44 |
Vitamin D and bone fracture healing
World J Pharmacol
3(4):199-208.
Published online Dec 9, 2014.
doi: 10.5497/wjp.v3.i4.199
|
| 45 |
Advances in the treatment of nonalcoholic steatohepatitis
World J Pharmacol
9(1):1-12.
Published online Oct 28, 2020.
doi: 10.5497/wjp.v9.i1.1
|
| 46 |
Importance of microenvironment in preclinical models of breast and prostate cancer
Maija Valta, Katja Fagerlund, Mari Suominen, Jussi Halleen, Johanna Tuomela
World J Pharmacol
4(1):47-57.
Published online Mar 9, 2015.
doi: 10.5497/wjp.v4.i1.47
|
| 47 |
Aryl hydrocarbon receptor as a new therapeutic target for cancer and immune disorders
Libia Vega, Guillermo Elizondo
World J Pharmacol
2(4):107-114.
Published online Dec 9, 2013.
doi: 10.5497/wjp.v2.i4.107
|
| 48 |
Challenges and opportunities in the treatment of ulcerative colitis
Sunil Ashokrao Nirmal, Sunil Shivaji Gangurde, Pratiksha Shankar Dumbre, Subodh Chandra Pal, Subhash Chandra Mandal
World J Pharmacol
4(2):219-226.
Published online Jun 9, 2015.
doi: 10.5497/wjp.v4.i2.219
|
| 49 |
Levomilnacipran and vortioxetine: Review of new pharmacotherapies for major depressive disorder
Mei T Liu, Megan E Maroney, Evelyn R Hermes-DeSantis
World J Pharmacol
4(1):17-30.
Published online Mar 9, 2015.
doi: 10.5497/wjp.v4.i1.17
|
| 50 |
Antidepressant-like potential of silymarin and silymarin-sertraline combination in mice: Highlighting effects on behaviour, oxidative stress, and neuroinflammation
Olakunle James Onaolapo, Anthony Tope Olofinnade, Hameed Sulaiman, Adejoke Yetunde Onaolapo
World J Pharmacol
11(3):27-47.
Published online Nov 28, 2022.
doi: 10.5497/wjp.v11.i3.27
|
